We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The investment seeks investment results, before fees and expenses, that track the performance of the LPX Direct Listed Private Equity Index (the index). The index consists of up to 30 qualifying listed private equity companies. The fund invests insecurities that ProShare Advisors believes, in combin... The investment seeks investment results, before fees and expenses, that track the performance of the LPX Direct Listed Private Equity Index (the index). The index consists of up to 30 qualifying listed private equity companies. The fund invests insecurities that ProShare Advisors believes, in combination, should track the performance of the index. It will invest at least 80% of its total assets in component securities. The fund will concentrate its investments in a particular industry or group of industries, country or region to approximately the same extent as the index is so concentrated. It is non-diversified. Show more
ProShares is best known as an ETF provider of leveraged and inverse funds and it is one of the main players in this market. However, the company has also made a big push into the unleveraged...
ProShares has long been a leader in the leverage and inverse ETF market. The company is probably best known for its S&P 500-focused funds—such as SH, SDS and SSO—although it has...
After an early year lull, ETF issuers are back on the product development trail with a series of new launches. While most of these have been innovative-option focused funds, we have also seen...
HILLSBOROUGH, Calif., June 2 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Amex: PEX) (the "Company") announced that at a special meeting of stockholders held today...
HILLSBOROUGH, Calif., May 11 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Amex: PEX) (the "Company") announced today that it has received notice from NYSE Amex LLC...
HILLSBOROUGH, Calif., May 7 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Amex: PEX) ("Apex") announced today that a special meeting of stockholders will be held at...
HILLSBOROUGH, Calif., March 5 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Alternext US: PEX) ("Apex") announced today that its board of directors has determined that...
HILLSBOROUGH, Calif., Feb. 13 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (NYSE Alternext US: PEX) announced today that it has received notice from NYSE Alternext US LLC...
HILLSBOROUGH, Calif., Dec. 15 /PRNewswire-FirstCall/ -- Apex Bioventures Acquisition Corporation (AMEX:PEX) announced today that, on December 13, 2008, it entered into a letter of intent with a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.25 | -0.88841506752 | 28.14 | 28.45 | 27.21 | 5070 | 27.7057237 | SP |
4 | -1.11 | -3.8275862069 | 29 | 29.25 | 27.21 | 3492 | 28.43672091 | SP |
12 | -0.38 | -1.34418111072 | 28.27 | 29.25 | 27.21 | 3085 | 28.3190677 | SP |
26 | -0.64 | -2.24325271644 | 28.53 | 29.69 | 26.43 | 2979 | 28.55492516 | SP |
52 | -0.42 | -1.48357470858 | 28.31 | 30.67 | 26.43 | 2800 | 28.89364772 | SP |
156 | -7.7 | -21.635290812 | 35.59 | 36.5099 | 23.03 | 3185 | 28.97914982 | SP |
260 | -6.5311 | -18.9741176197 | 34.4211 | 39.0115 | 17.49 | 2790 | 29.61713195 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions